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Abstract Glycolipid biosurfactants produced by
bacteria and yeasts provide significant opportunities
to replace chemical surfactants with sustainable bio-
logically produced alternatives in bulk commercial
products such as laundry detergents and surface
cleaners. Sophorolipids are already available in suf-
ficient yield to make their use feasible while rhamn-
olipids and mannosylerythritol lipids require further
development. The ability to tailor the biosurfactant
produced to the specific needs of the product formu-
lation will be an important future step.
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Introduction
Biosurfactants are produced mainly, but not exclu-
sively, by microorganisms both bacteria and fungi
(including yeasts), and have surface active properties.
These surface interactions are mediated by the amphi-
philic nature of the molecules, which have hydrophilic
and hydrophobic regions, allowing them to act as
surfactants at the interfaces between aqueous and non-
aqueous components in a complex system and at the
liquid gas interface. Some of these molecules are
effective emulsifiers while others reduce surface
tension at oil water interfaces. The differences in
solubility, surface and interface reducing capability,
critical micelle concentration together with deter-
gency, wetting and foaming will make a given
surfactant more or less suitable for a particular
application (Myers 2006).
Similar properties are displayed by chemically-
synthesised surfactants which come from petrochem-
ical or oleochemical sources (Desai and Banat 1997)
and these compounds have been extensively devel-
oped for large scale industrial applications, particu-
larly in the area of cleaning products such as
detergents and surface cleaners. The vigorous current
movement for industrial sustainability has stimulated
active interest in biosurfactants as possible replace-
ments for at least some of these chemical surfactants.
In addition to biosurfactants being produced from
renewable feedstocks, they also have characteristics
that fall under the overused and inaccurate term
‘environmentally friendly.’ The fact that they can be
readily biodegraded means that they are significantly
less damaging to the environment than the more
recalcitrant chemical surfactants and their ability to
withstand high temperatures and to tolerate high salt
concentrations makes them attractive components for
many industrial products (Banat et al. 2010). This
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short review will concentrate on a specific group of
biosurfactants that fall in the glycolipid category and
which have become the target for industrial attention
over the last few years. In particular we will look at
the sophorolipids, the rhamnolipids and the mann-
osylerythritol lipids (MELS) and examine the current
situation and future prospects for each focussing on
the areas of research that are underway and those that
are needed for further development and exploitation to
take place.
The structure of glycolipid biosurfactants
Microbially-produced biosurfactants fall into two
major categories, low molecular weight (LMW) and
high molecular weight (HMW) (Ron and Rosenberg
2001; Smyth et al. 2010b, c). In this review we will
only consider the LMW biosurfactants and, in partic-
ular, the glycolipid members of this group rather than
the lipopeptides. The glycolipid biosurfactants com-
prise a hydrophilic carbohydrate section and a hydro-
phobic fatty acid chain. The sugar at the hydrophilic
end is sophorose in the sophorolipids, rhamnose in the
rhamnolipids and mannose and erythritol in MELS.
There are a few other glycolipid biosurfactants e.g.
trehalose lipids and cellobiose lipids but they have so
far attracted less interest.
The sophorolipids are produced by yeasts of
the genus Candida, particularly C. bombicola and
C. apicola, and are produced in mixtures comprising
usually 8 major and up to 15 minor components
(Table 1) (van Bogaert et al. 2007). Sophorose, a 1,2-
disaccharide of glucose, forms the hydrophilic head of
the molecule that may or may not be acetylated with
one or two acetyl groups. The fatty acid chain typically
has 16 or 18 carbon atoms with different degrees of
saturation (none, one or two double bonds). Sophor-
olipid molecules exist either in the acidic or lactonic
form; in the latter, the carboxylic end of the fatty acid
is esterified at the 400-, or less frequently at the 60- or
600-position, of the sophorose unit. The possible
variants make the sophorolipid mixture produced by
Candida species very complex, although lactonic
sophorolipid with 17-hydroxy-octadecanoic acid is
reported to be the predominant congener (van Bogaert
et al. 2007).
Some control over the sophorolipid structures
produced can be achieved through strain selection
and changes to the culture conditions, however it is not
possible to alter the functional backbone by feeding
sugars other than glucose (Klekner et al. 1991) or fatty
acids with a shorter or longer carbon chain (Van
Bogaert et al. 2011) (Fig. 1).
Rhamnolipids are produced most abundantly by the
bacterium Pseudomonas aeruginosa, although other
reports have indicated that rhamnolipid biosurfactants
are also produced by Pseudomonas chlororaphis
strain NRRL B-30761 which synthesises only mono-
rhamnolipids using C10 and C12:1 fatty acyl chains
(Gunther et al. 2005) and Burkholderia thailandensis
(Dubeau et al. 2009) which only produces di-rhamn-
olipid with b-hydroxy-tetradecanoic acid (C14) and
Burkholderia pseudomallei (Haussler et al. 1998)
which is similar to B. thailandensis. Significantly,
P. chlororaphis and B. thailandensis are have no
known human pathogenicity, which would make them
Table 1 Representative
chemical composition of
sophorolipid mixture
produced by C. apicola
ATCC 96134 in a
bioreactor fermentation
with oleic acid as the major
carbon source based on
HPLC data (unpublished
data)
The three main sophorolipid
congeners are reported in
bold
No. Possible structure RT (min) (m/z) Abundance (%)
1 Acidic, C18:1 6.93 621 6.5
2 Acidic, C18:1, 1Ac 7.93 663 4.9
3 Acidic, C18:2, 2Ac 9.84 703 2.8
4 Acidic, C18:1, 2Ac 12.13 705 48.1
5 Acidic, C18:0, 2Ac 16.54 707 2.8
6 Lactonic, C18:1, 1Ac 24.69 645 3.06
7 Lactonic, C18:2, 2Ac 36.45 685 2.7
8 Lactonic, C18:2, 2Ac 39.25 685 2.2
9 Lactonic, C16:0, 2Ac 44.21 661 1.1
10 Lactonic, C18:1, 2Ac 47.73 687 4.6
11 Lactonic, C18:1, 2Ac 49.68 687 10.0
12 Lactonic, C18:0, 2Ac 67.92 689 4.1
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attractive organisms to use for large-scale fermenta-
tion production of rhamnolipids. [Published reports of
rhamnolipid production by Pseudomonas fluorescens
(Vasileva-Tonkova et al. 2006, Stoimenova et al.
2009), however, could not be verified by us.] P. aeru-
ginosa produces two types of rhamnolipid: the mono-
and di- forms which have one or two molecules of
rhamnose, respectively, attached to b-hydroxy-deca-
noic acid chains (Sobero´n-Cha´vez et al. 2005).
Although a range of different alkyl chain lengths
occur the C10 C10 configuration predominates and the
quantities of other minor congeners only vary slightly
with substrate and culture conditions (Table 2) (Per-
fumo et al. 2006).
Since the synthetic pathway proceeds through
mono-rhamnolipid to di-rhamnolipid by the addition
of a molecule of rhamnose by a specific rhamnosyl
transferase, opportunities to manipulate the propor-
tions of the two main congeners by manipulating
growth conditions are limited.
MELs are produced by basidiomycetous yeasts of
the genus Pseudozyma (P. rugulosa, P. aphidis and
P. antarctica) and by species of the fungus Ustilago
(Arutchelvi et al. 2008). MELs form the main compo-
nent of the Pseudozyma biosurfactants but are only a
minor component of that produced by Ustilago. MELs
have four major structural groups comprising 4-O-b-D-
mannopyranosyl-D-erythritol connected to two med-
ium length chains of fatty acyl esters (Fig. 2) (Fukuoka
et al. 2007). As with the other microbial biosurfactants,
Pseudozyma yeasts produce a mixture of congeners
rather than a single predominant molecule. The
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Fig. 1 Structures of
biosurfactants: mono-
rhamnolipid (a) and
di-rhamnolipid (b) from
P. aeruginosa in which one
and two molecules of
rhamnose are linked to two
b-hydroxy-decanoic acid
chains; sophorolipid in open
chain (c) and lactonic
(d) form from C. bombicola
in which one molecule of
sophorose is linked to a
chain of hydroxyl-fatty acid
(n = 15, R1 and R2 = H
and/or COCH3
Table 2 Representative
chemical composition of
rhamnolipid mixture
produced by P. aeruginosa
ST5 in a bioreactor
fermentation with glycerol
as the major carbon source
based on HPLC data
(unpublished data)
The two main rhamnolipid
congeners are reported in
bold
No. Molecular congener (m/z) RT (min) Abundance (%)
1 Rha-C8-C10/Rha-C10-C8 475 12.80 5.00
2 Rha-C10-C10 503 22.25 34.0
3 Rha-C10-C12:1/Rha-C12:1-C10 529 28.24 2.2
4 Rha-C10-C12/Rha-C12-C10 531 35.89 2.9
5 Rha–Rha-C8-C10/
Rha–Rha-C10-C8
621 9.01 6.1
6 Rha–Rha-C10-C10 649 15.95 42.2
7 Rha–Rha-C10-C12:1/
Rha–Rha-C12:1-C10
675 24.60 2.5
8 Rha–Rha-C10-C12/
Rha–Rha-C12-C10
677 25.35 6.5
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naturally-produced MELS are acylated structures with
either two acyl groups MEL-A, MEL-B and MEL-C or
three acyl groups, although Fukuoka et al. (2007) have
also reported the formation of a mono-acylated MEL
produced by Pseudozyma antarctica grown on glu-
cose. In addition to the variation induced by the level of
acylation in the MELS produced, the fatty acid chains
are also not of a consistent length or degree of
unsaturation. Fukuoka et al. (2007) reported chain
lengths from C6 to C16 in MELS with [75 % of the
MEL-A in P. antarctica grown on soybean oil made up
of C8 and C10 chain length molecules. In many of the
MEL producers belonging to the genus Pseudozyma,
MEL-A is the predominant product comprising 70 %
of the total biosurfactant produced. Unfortunately the
low water solubility of MEL-A limits its potential
commercial use.
Efficacy for specific applications
As we have seen, the glycolipid biosurfactants are
produced by microorganisms in complex mixtures
with more than one major component. If they are to be
used in commercial formulations it is essential to
determine whether all the components behave simi-
larly or whether separation, purification or enrichment
of one component would be desirable and cost
effective. To this end, detailed investigation of the
self-assembly and surface activity at the air/water
interface of sophorolipids (Penfold et al. 2011; Chen
et al. 2011) and rhamnolipids (Chen et al. 2010a, b)
have been carried out using neutron beam scattering
techniques. To carry out this work effectively surfac-
tant molecules labelled with deuterium atoms are
required, however, many microorganisms, particularly
bacteria react adversely to deuterated substrates. A
progressive adaptation programme can overcome the
problem and, by careful use of deuterated substrates
and deuterated water in the growth medium, selective
labelling of different parts of the surfactant molecule
can be achieved (Smyth et al. 2010a). The investigation
of the behaviour of the biosurfactants alone and in
combination with synthetic surfactants which are
employed in current cleaning product formulations
such as sodium dodecyl benzene sulfonate (LAS) has
shown that the different forms produced behave
differently. These varying behaviours are due to the
size and structure of the molecules, for example
micelle sizes are different between the mono and
dirhamnolipids and aggregation of the acidic and
lactonic forms of sophorolipid are not identical. The
more hydrophobic lactonic form is more surface active
than the acidic form, with a lower critical micellar
concentration, CMC, and stronger surface adsorption.
Depending on the function required for the biosurfac-
tant in a final product formulation there will be a
requirement for either a single form of the molecule to
be available or for the naturally produced mixture to be
manipulated to give changed ratios of components.
Opportunities to improve naturally-occurring
biosurfactants
The simplest approach to achieve different ratios of
biosurfactants in the mixed products is to examine
different strains of the producer organism combined
with different culture conditions. In the case of the
rhamnolipids produced by P. aeruginosa, this strategy
has not been successful since in a wide range of freshly
isolated strains similar production patterns were
observed (A. Perfumo unpublished results) and
although yield can be modified significantly by
changing the growth conditions the composition is
relatively stable (Mata-Sandoval et al. 2001).
The other possibility is to take the mixed
product and to carry out a chemical separation of
the components; while this is feasible on a small
scale the column chromatography techniques nec-
essary to separate similar molecules are not
economic on a large scale (Smyth et al. 2010b).
The pathway for rhamnolipid formation proceeds
through hydroxyl-alkanoic acid (HAA) with the
subsequent addition of one rhamnose molecule to
form mono rhamnolipid and thence by a further
Fig. 2 Structure of MELS MEL-A: R1 = R2 = Ac MEL-B:
R1 = Ac, R2 = H: MEL-C R1 = H, R2 = Ac fatty acid chain
length n = 6–10* indicates point of attachment for a further
fatty acid chain (n = 12–16) with a terminal acyl group in the
tri-acylated MEL (Adapted from Fukuoka et al. (2007))
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rhamnose addition to di-rhamnolipid (Fig. 3) (Zhu
and Rock 2008).
This provides an opportunity to knock-out the
second rhamnosyl transferase gene (rhlC) and to
produce a strain producing only mono rhamnolipid.
Such a knock-out has been achieved in a study of
swarming patterns, but a complete investigation of the
yields of mono rhamnolipid possible have not been
made (Caiazza et al. 2005), however, the kinetic
characteristics of the rhlB gene product may severely
limit the yields of mono rhamnolipid possible.
Another molecular biology approach is to clone the
rhamnolipid operon, or parts of it, into a different
organism. This is a potentially attractive option since
the fact that P. aeruginosa is a class II organism is a
strong disincentive for large scale fermentation appli-
cations. Once again this has been achieved (Ochsner
et al. 1994) but the resulting yields of rhamnolipid
were very low, as might be expected since production
of the rhamnolipid will depend on the metabolic flux
of the precursors within the recipient strain. Currently
interest is centered on investigation of the few other
known non-pathogenic rhamnolipid producing bacte-
ria one of which apparently produces only mono
rhamnolipid (P. chlororaphis, Gunther et al. 2005) and
another predominantly di-rhamnolipid although with
longer acyl chains than P. aeruginosa (Burkholderia
thailandensis, Dubeau et al. 2009). It is already clear
that the presence of C14 chain length acyl moieties in
the di-rhamnolipid of B. thailandensis produces a
surfactant that does not reduce the surface tension of
the growth medium in the dramatic way that occurs
with P. aeruginosa (unpublished results) indicating
that this product may have very different applications
in commercial formulations.
Sophorolipids have already found applications in
domestic products, particularly in Japan and Korea.
The rapid uptake of these biosurfactants into mature
product areas has been driven to a large extent by the
fact that high yields of sophorolipids ([100 g/l) are
relatively easy to achieve in culture and this, in turn,
makes purification and downstream processing eco-
nomically attractive. However, the low cost and ease
of production does not necessarily mean that these
biosurfactants are the most effective molecules avail-
able and there are large behaviour differences between
the acidic and lactonic forms of the molecules
(Penfold et al. 2011). The complexity of the mixtures
of molecules produced by the Candida species cou-
pled with the chemical similarity of the products again
means that separation and purification methods on an
industrial scale are not economically attractive. This
has led to an interest in tailoring the sophorolipids
produced specifically for industrial needs through
genetic manipulation. The first important steps in this
pathway have already been completed and work is
ongoing to expand the extent and application of this
work. Recently, new-to-nature sophorolipids have
been produced by genetic manipulation of Candida
bombicola (Saerens et al. 2011; Van Bogaert et al.
2009). This new approach should allow changes to be
introduced into both the carbohydrate head and the
lipid tail of the sophorolipids, including changes to
the chain length and degree of saturation of the tail and
the degree of acetylation of the carbohydrate. Control
over the formation of the lactonic form of the surfactants
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2. Acyl-ACP 
FASII cycle 
3. β -ketoacyl-ACP
4. β -hydroxyacyl-ACP
RhlA 
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Mono-rhamnolipid 
RhlC + dTDP-L-rhamnose 
Di-rhamnolipid 
O
OH
CH3
OH
O O CH CH2 COOHCH2CHOC
O
H
(CH2)6
CH3
(CH2)6
CH3
H O
OH
CH3
OH
O O
CH3
(CH2)6
CH3
(CH2)6
H O
CH3
OH
O O CH CH2 COOHCH2CHOC
O
Fig. 3 Proposed pathway for the synthesis of rhamnolipids in
P. aeruginosa
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should also be achievable. Whether after such genetic
manipulation strains can be produced that will give
commercially viable yields remains to be determined.
The gene cluster responsible for the synthesis of
MELS in Ustilago maydis under conditions of nitrogen
limitation have been described by Hewald et al. (2006).
The MEL biosynthesis gene cluster comprises the mat1
acetyltransferase gene, the mmf1 gene, which specifies a
member of the major facilitator family, mac1 and mac2,
encoding putative acyltransferases, and the glycosyl-
transferase gene emt1. Deletion of the mat 1 gene
resulted in the production of completely deacylated
MELS. This again offers the opportunity to produce a
modified product through genetic manipulation.
A different approach to modifying biosurfactants
has recently been reported by Fukuoka et al. (2011).
These workers took a naturally produced acylated
MEL and removed the acyl groups through a lipase-
catalysed hydrolysis, producing a non-acylated prod-
uct which they designated MEL-D. They were able to
show that the non-acylated form of MEL had a higher
critical aggregation concentration but retained an
excellent surface tension lowering capacity. These
results suggest that the new MEL-D may have
applications in fields where a lamellar-forming gly-
colipid is required.
Cost and production
In all potential commercial applications cost of
production is critical in determining whether a new
compound can be incorporated into a formulation. The
initial step is to determine whether the component, in
this case a biosurfactant, has the required character-
istics to replace some or all of the existing chemical
surfactants. This work has been carried out and
biosurfactants have been identified as potentially
useful sustainable ingredients for a number of com-
mercial products. The next step is to determine
whether the biosurfactant can be produced at a price
which will make it competitive with existing chemical
surfactants. Production costs for biosurfactants will
depend on the cost of fermentation feedstock used
(Makkar et al. 2011), the yield in the fermentation
broth and the cost of downstream processing and the
interaction between each of these factors. For example
the downstream processing may be made more
difficult and costly if an oily substrate is used rather
than glycerol.
At the present time sophorolipids can be produced
at a price that allows their use in some commercial
formulations. This is mainly because relatively long
fed batch fermentations using resting cells can be used
with high oleic acid substrate levels to give very high
yields. The use of well aerated bioreactors has been
shown to produce higher levels of the lactonic form of
the sophorolipids (Casas and Garcia-Ochoa 1999;
Guilmanov et al. 2002) a situation which is probably
enhanced by the long fermentation time since the
lactonisation step is the last in the synthetic pathway
(Davila et al. 1997). The possible use of glycerol as a
feedstock, a cheap and plentiful by-product derived
from the production of biodiesel from glycerides, may
make future production even cheaper. The high yield
of sophorolipids in Candida is possible since the
synthetic pathway continues to operate in non-grow-
ing cells.
The production of rhamnolipids by P. aeruginosa is
in sharp contrast to the production of sophorolipids. In
the majority of strains maximum production is around
10 g/l in a batch bioreactor system, although there
have been reports of much higher yields of around
100 g/l from hyperproducer strains (Lang and Wull-
brandt 1999). Oil-containing agricultural by-products
and wastes can be used as feedstocks for rhamnolipid
production but the unused residues make downstream
processing far more difficult. Glycerol does, however,
provide a possible satisfactory feedstock for rhamn-
olipids. The major obstacle to obtaining high yields of
rhamnolipid from P. aeruginosa is that the synthetic
pathway is part of the quorum sensing system and is
under tight genetic regulation. Recent investigations in
out laboratory (unpublished results) using qRT PCR
have shown that the rhamnosyl transferase coded by
the rhlB gene which leads to the formation of the mono
rhamnolipid is induced during mid exponential phase
of growth, followed by the induction of the rhlC gene
product, the rhamnosyl transferase producing the di
rhamnolipid, during early stationary phase. However
the transcription of both genes is then shut down as the
cells enter full stationary phase indicating that pro-
longation of the fermentation in the presence of excess
substrate will not produce further biosurfactant. An
alternative approach such as cell immobilisation and
continuous flow may prove more useful.
Large-scale production of MELs does not appear to
have been attempted yet, although Kitamoto et al.
(2001) reported yields of[100 g/l from P. antarctica
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grown on vegetable oils. Pseudozyma yeasts are also
able to grow and produce MELS on a range of other
low cost substrates, some of which can be considered
as by-products or wastes, which makes the prospect of
commercial production more inviting. Yields at this
level indicate that the control of synthesis of MELS in
Pseudozyma may mirror the situation in Candida
where high yields of commercially viable sophoroli-
pids can be obtained.
New applications
Much of the industrial interest in biosurfactants has
until now been directed at the bulk product markets,
such as laundry detergents and domestic cleaning
products. There are, however, many other applications
where chemical surfactants are currently used and
where some of the special properties of biosurfactants
might be usefully employed. One such application is
in relation to the formation and disruption of bacterial
biofilms (Rodrigues et al. 2007) and other general
medically-related applications (Rodrigues et al. 2006).
The production of biosurfactants by bacteria has been
linked with a number of different functions including
motility, adhesion substrate utilisation and biofilm
formation (Van Hamme et al. 2006; Fracchia et al.
2012). The role of rhamnolipids in the maintenance of
biofilm structure is based on a dynamic disruption of
the continuous structure, allowing diffusion of nutri-
ents and gases to the cells within the biofilm. This
suggests that biosurfactants might have a useful
application in preventing the formation of biofilms
on surfaces such as catheters or might be used to
disrupt established biofilms on surfaces through their
use in surface cleaning formulations (Dusane et al.
2010). Domestic surface-cleaning products already
contain chemical surfactants which are not specifically
effective at disrupting biofilms and their replacement
with biosurfactants offers an exciting new application.
The move to produce laundry detergents which can be
used in washing machines at low wash temperatures
has created a new biofilm situation in the waste pipes
where previously high water temperatures inhibited
biofilm formation. The presence of biosurfactants in
the laundry detergent formulations may also help to
overcome this problem.
A relatively new area of application for biosurfac-
tants has appeared with the suggestion that biosurfac-
tants may aid wound healing (Piljac et al. 2008). Once
again this opens the possibility that biosurfactants
could usefully be incorporated into a wide range of
skin care products in place of chemical surfactants and
that this would have the added benefit of aiding the
healing of minor skin lesions.
One final area where large scale replacement of
chemical surfactants could take place is in the environ-
mental remediation field. The fact that biosurfactants are
readily biodegradable would be particularly attractive
where large quantities of these chemicals are used in, for
example, oil spill remediation exercises. There would
also be an added benefit on top of the simple oil
dispersion and emulsification process since biosurfac-
tant production by bacteria forms a mechanism to
enhance access to oil substrates for their growth
(Perfumo et al. 2010). Enhanced biodegradation in situ
would be of considerable benefit in accelerating the
bioremediation process and in turn reducing the overall
cost of the environmental damage caused (Franzetti
et al. 2011).
Conclusions
Several of the glycolipid biosurfactants produced by
microorganisms offer exciting prospects for future
sustainability of large scale commercial products.
Progress is currently being made in solving some of
the remaining problems associated with biosurfactant
use i.e. yield, cost, downstream processing and tailor-
ing of biosurfactant molecules to fulfill specific roles in
product formulations. Products are already on the
market containing biosurfactants and we can expect to
see further exploitation in the near future.
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